High-density oligonucleotide microarrays and functional network analysis reveal extended lung carcinogenesis pathway maps and multiple interacting genes in NNK [4-(methylnitrosamino)-1-(3-pyridyle)-1-butanone] induced CD1 mouse lung tumor

被引:19
作者
Abdel-Aziz, Hekmat Osman
Takasaki, Ichiro
Tabuchi, Yoshiaki
Nomoto, Kazuhiro
Murai, Yoshihiro
Tsuneyama, Koichi
Takano, Yasuo
机构
[1] Toyama Univ, Dept Diagnost Pathol, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan
[2] Toyama Univ, Div Mol Genet Res, Life Sci Res Ctr, Toyama 9300194, Japan
关键词
NNK; CD1; mouse; lung tumor; oligonucleotide microarrays; IPA;
D O I
10.1007/s00432-006-0149-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose NNK [4-(methylnitrosamino)-1-(3-pyridyle)-1-butanone] is a nicotine-derived nitrosaminoketone contained in tobacco smoke used as a powerful chemical carcinogen for rodent experimental models of pulmonary carcinogenesis. To clarify its carcinogenetic mechanisms, we examined the expression status of 22,625 mouse genes. Methods The affymetrix GeneChip mouse expression 430 A arrays have been used in CD1-induced mouse lung tumor. The affected genes were analyzed by Ingenuity pathway analysis to investigate functional network and gene ontology. Results A total of 876 genes were found to be differentially expressed at least twofold between NNK-induced tumors and normal lung tissues, 390 up-regulated and 486 down-regulated in these lesions. The functions with the highest P values were related to cellular growth and proliferation (P = 1.71 x 10(-4) to 4.10 x 10(-2)). In addition, we identified canonical pathways for Wnt/beta-catenin signaling (P = 0.0338). Conclusions These results suggest that application of gene expression profiling may provide an improved strategy for therapeutic targeting of tobacco smoking-induced lung cancer.
引用
收藏
页码:107 / 115
页数:9
相关论文
共 33 条
[1]  
[Anonymous], 2001, INT CLASSIFICATION R
[2]  
BELINSKY SA, 1992, CANCER RES, V52, P3164
[3]   Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses [J].
Bhattacharjee, A ;
Richards, WG ;
Staunton, J ;
Li, C ;
Monti, S ;
Vasa, P ;
Ladd, C ;
Beheshti, J ;
Bueno, R ;
Gillette, M ;
Loda, M ;
Weber, G ;
Mark, EJ ;
Lander, ES ;
Wong, W ;
Johnson, BE ;
Golub, TR ;
Sugarbaker, DJ ;
Meyerson, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13790-13795
[4]   Lung adenocarcinoma global profiling identifies type II transforming growth factor-β receptor as a repressor of invasiveness [J].
Borczuk, AC ;
Kim, HK ;
Yegen, HA ;
Friedman, RA ;
Powell, CA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (06) :729-737
[5]   Inhibition of lung tumourigenesis by sulindac: Comparison of two experimental protocols [J].
Castonguay, A ;
Rioux, N .
CARCINOGENESIS, 1997, 18 (03) :491-496
[6]  
Charalabopoulos K, 2004, EXP ONCOL, V26, P256
[7]   Transcriptional silencing of secreted frizzled related protein 1 (SFRP1) by promoter hypermethylation in non-small-cell lung cancer [J].
Fukui, T ;
Kondo, M ;
Ito, G ;
Maeda, O ;
Sato, N ;
Yoshioka, H ;
Yokoi, K ;
Ueda, Y ;
Shimokata, K ;
Sekido, Y .
ONCOGENE, 2005, 24 (41) :6323-6327
[8]   Gene expression profiling in respiratory tissues from rats exposed to mainstream cigarette smoke [J].
Gebel, S ;
Gerstmayer, B ;
Bosio, A ;
Haussmann, HJ ;
Van Miert, E ;
Müller, T .
CARCINOGENESIS, 2004, 25 (02) :169-178
[9]   Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines [J].
Hecht, SS .
CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (06) :559-603
[10]   Tobacco smoke carcinogens and lung cancer [J].
Hecht, SS .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (14) :1194-1210